Work

Establishment of an Integrated Population Pharmacokinetic/ Pharmacodynamics Model of Apixaban in Chinese Healthy Population Adjusting for Key Genetic Variants

Year: 2024

Type: article

Source: Current Pharmaceutical Design

DOI: 10.2174/0113816128306062241007053405

Authors: Guangyan Mu, Yaou Liu, Qiufen Xie, Zhiyan Liu, Hanxu Zhang, Xianmin Meng, Jinfang Song, Zhe Wang, Shuang Zhou, Zining Wang, Kun Hu, Xia Zhao, Maoxing Liao, Jiachun Bao, Qian Xiang, Yimin Cui

Institutions: Peking University First Hospital, Tianjin Medical University General Hospital, Tianjin Medical University, Fudan University, Shanghai Public Health Clinical Center, Wuxi Fourth People's Hospital

Language: English

Topic: Pharmacogenetics and Drug Metabolism

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Peking University First Hospital, National Natural Science Foundation of China, National Science and Technology Major Project, National Key Research and Development Program of China

Awards: G3096639218, G4473767866, G6205888505, G6895586517, G7643943869

OpenAlex ID: W4403776954

FWCI:

Cites: 43

Cited by:

Related to: 10